Patents by Inventor Vyara Matson

Vyara Matson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Microbiome biomarkers immunotherapy responsiveness: diagnostic, prognostic and therapeutic uses thereof
    Patent number: 11638728
    Abstract: Provided herein are compositions and methods comprising microbiome biomarkers of responsiveness/resistance to immunotherapy (e.g., anti-PD1/PD-L1 therapy), and diagnostic, prognostic and therapeutic uses thereof. In particular, the amount, identity, presence, and/or ratio of microflora in the microbiome of a subject is used to determine the responsiveness/resistance of the subject to immunotherapy, and/or the microbiome of a subject is manipulated to enhance the responsiveness of the subject to various immunotherapies and co-therapies.
    Type: Grant
    Filed: June 5, 2018
    Date of Patent: May 2, 2023
    Assignee: The University of Chicago
    Inventors: Thomas F. Gajewski, Jason Luke, Riyue Bao, Vyara Matson, Jessica Fessler
  • MICROBIOME BIOMARKERS IMMUNOTHERAPY RESPONSIVENESS: DIAGNOSTIC, PROGNOSTIC AND THERAPEUTIC USES THEREOF
    Publication number: 20210177918
    Abstract: Provided herein are compositions and methods comprising microbiome biomarkers of responsiveness/resistance to immunotherapy (e.g., anti-PD1/PD-L1 therapy), and diagnostic, prognostic and therapeutic uses thereof. In particular, the amount, identity, presence, and/or ratio of microflora in the microbiome of a subject is used to determine the responsiveness/resistance of the subject to immunotherapy, and/or the microbiome of a subject is manipulated to enhance the responsiveness of the subject to various immunotherapies and co-therapies.
    Type: Application
    Filed: June 5, 2018
    Publication date: June 17, 2021
    Inventors: Thomas F. Gajewski, Jason Luke, Riyue Bao, Vyara Matson, Jessica Fessler